SREBF2 and metabolic dysfunction-associated steatotic liver disease: In this sense, our NAFLD patients showed increased expression levels of SREBP2 and ABCG1, genes involved in lipoprotein secretion, and CROT and FAS, which are related to lipid oxidation and hepatic lipid accumulation [23,24].